Despite Challenges, Ebola Vaccine Research Continues In West African Nations

The Lancet: Ebola vaccines line up while industry calls for change
“As the West African Ebola outbreak slows, the world has a suite of experimental vaccines in various stages of development. But manufacturers are warning of problems ahead…” (Petherick, 10/10).

Reuters: J&J starts vaccine trial in Sierra Leone, even as Ebola fades
“Johnson & Johnson has begun a clinical trial of a two-shot Ebola vaccine in Sierra Leone, underlining its determination to push ahead with development, even as the epidemic fades out in West Africa…” (Hirschler, 10/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.